Intravascular brachytherapy for peripheral vascular disease

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 1, 2014, Pages

  Andras, Alina ^a   Hansrani, Monica ^b   Stewart, Marlene ^c   Stansby, Gerard ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENT; ANKLE BRACHIAL INDEX; BLEEDING; BRACHYTHERAPY; BYPASS SURGERY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DISEASE DURATION; FEMOROPOPLITEAL BYPASS; FOLLOW UP; HEALTH ECONOMICS; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR BRACHYTHERAPY; LIMB AMPUTATION; LIMB SALVAGE; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; TREADMILL TEST; VASCULAR PATENCY; WALK TEST; ADJUVANT THERAPY; ANGIOPLASTY; ENDOVASCULAR SURGERY; FEMORAL ARTERY; META ANALYSIS; METHODOLOGY; POPLITEAL ARTERY; STENT;

ANGIOPLASTY; BRACHYTHERAPY; ENDOVASCULAR PROCEDURES; FEMORAL ARTERY; HUMANS; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; VASCULAR PATENCY;

EID: 84903762824     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003504.pub2     Document Type: Review

References (125)

1. Krueger K, Landwehr P, Bendel M, Nolte M, Stuetzer H, Bongartz R, et al.Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trial. Radiology 2002;224(2):519-28.
2. Krueger K, Zaehringer M, Bendel M, Stuetzer H, Strohe D, Nolte M, et al.De novo femoropopliteal stenoses: endovascular gamma irradiation following angioplasty - angiographic and clinical follow-up in a prospective randomized controlled trial. Radiology 2004;231(2):546-54.
3. Bonvini R, Baumgartner I, Do DD, Alerci M, Segatto JM, Tutta P, et al.Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries. Journal of the American College of Cardiology 2003;41(3):409-12.
4. Diehm N, Silvestro A, Do DD, Greiner R, Triller J, Mahler F, et al.Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time. Journal of Endovascular Therapy 2005;12(6):723-30.
5. Gallino A, Do DD, Alerci M, Baumgartner I, Cozzi L, Segatto JM, et al.Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial. Journal of Endovascular Therapy 2004;11(6):595-604.
6. Wyttenbach R, Corti R, Alerci M, Cozzi L, Di Valentino M, Segatto JM, et al.Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery: 2 years follow-up by noninvasive magnetic resonance imaging. European Journal of Vascular and Endovascular Surgery 2007;34(4):416-23.
7. Wyttenbach R, Gallino A, Alerci M, Mahler F, Cozzi L, Di Valentino M, et al.Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 2004;110(9):1156-61.
8. Schillinger M, Minar E. Advances in vascular brachytherapy over the last 10 years: Focus on femoropopliteal applications. Journal of Endovascular Therapy 2004;11 Suppl 1:II180-91.
9. Waksman R. Result of the PARIS trial. Annual Transcatheter Cardiovascular Therapeutics meeting. Washington DC, September 2003.
10. Diehm N, Silvestro A, Do DD, Greiner R, Triller J, Mahler F, et al.Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time. Journal of Endovascular Therapy 2005;12(6):723-30.
11. Zehnder T, von Briel C, Baumgartner I, Triller J, Greiner R, Mahler F, et al.Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions. Journal of Endovascular Therapy 2003;10(2):304-11.
12. Hagenaars T, Apo IF, Van Sambeek MR, Coen VL, Van Tongeren RB, Gescher FM, et al.Gamma radiation induces positive vascular remodeling after balloon angioplasty: a prospective, randomized intravascular ultrasound scan study. Journal of Vascular Surgery 2002;36(2):318-24.
13. Van Tongeren RB, Van Sambeek MR, van Overhagen H, Coen VL, Schmitz PI, Gescher FM, et al.Endovascular brachytherapy for the prevention of restenosis after femoropopliteal angioplasty. Results of the VARA Trial. Journal of Cardiovascular Surgery 2005;46(4):437-43.
14. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlbock M, et al.Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 2000;102(22):2694-9.
15. Pokrajac B, Minar E, Maca T, Knocke TH, Fellner C, Ahmadi R, et al.Intraarterial 192Ir HDR BT for prophylaxis of restenosis after femoropopliteal transluminal angioplasty; prospective; randomised trial - Vienna 2; results after 6 months minimum follow-up; risk factor analysis. International Journal of Radiation Oncology, Biology, Physics 1999;45(3):181 Abstract 67.
16. Pokrajac B, Potter R, Maca T, Fellner C, Mittlbock M, Ahmadi R, et al.Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. International Journal of Radiation Oncology, Biology, Physics 2000;48(4):923-31.
17. Pokrajac B, Schmid R, Kirisits C, Mock U, Fellner C, Wambersie A, et al.Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. Radiotherapy and Oncology 2002;63(1):97-102.
18. Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up--prospective randomized study. Radiology 2006;240(3):878-84.
19. Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E. Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery--the Vienna experience. Radiology 2005;236(1):338-42.
20. Hofmann WJ, Kopp M, Kofler B, Ugurluoglu A, Kogelnik D, Magometschnigg H. Preliminary observations on the need for control angiography after peripheral endovascular brachytherapy using a centering balloon. Journal of Endovascular Therapy 2002;9(2):241-5.
21. Pokrajac B, Potter R, Wolfram RM, Budinsky AC, Kirisits C, Lileg B, et al.Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiotherapy and Oncology 2005;74(1):3-9.
22. Pokrajac B, Schmid R, Poetter R, Wolfram R, Kirisits C, Kopp M, et al.Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 multicenter study. International Journal of Radiation Oncology, Biology, Physics 2003; Vol. 57, issue 2, Suppl:S250.
23. Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E. Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery--the Vienna experience. Radiology 2005;236(1):338-42.
24. Wolfram RM, Pokrajac B, Budinsky AC, Potter R, Minar E. Five year to follow-up after endovascular brachytherapy for the prevention of restenosis after femoropopliteal angioplasty. Circulation 2004;110(III):647.
25. Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E. Vascular brachytherapy with 192Iridium after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. Radiology 2005;236(1):343-51.
26. Boselli G, Benincasa A, Lo G, Casali G, Tusini N, Vecchiati E, et al.Percutaneous transluminal angioplasty stent implantation and intravascular high dose rate brachytherapy in femoro-popliteal arteries. Giornale Italiano di Chirurgia Vascolare 2002;9(4):347-55.
27. Bottcher HD, Schopohl B, Liermann D, Kollath J, Adamietz IA. Endovascular irradiation--a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. International Journal of Radiation Oncology, Biology, Physics 1994;29(1):183-6.
28. Kruger K, Bendel M, Zahringer M, Bongartz R, Nolte M, Schulte O, et al.Endovascular gamma-irradiation for prevention of restenosis after angioplasty of femoropopliteal denovo stenoses; long term results of a feasibility study. RöFo: Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2002;174(3):321-7.
29. Liermann D, Kirchner J, Bauernsachs R, Schopohl B, Bottcher HD. Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries. An update. Herz 1998;23(6):394-400.
30. Novoste . The LIMBER trial (Limb ischemia treatment and monitoring post vascular brachytherapy to prevent restenosis).
31. Novoste . Corona system. Patient guide and information leaflet. http://www.bestvascular.com/assets/Beta-Cath%203.5F%20%205F%20Systems%20Dose%20Equivalency.pdf (accessed 22 May 2013).
32. Waksman R, Laird JR, Jurkovitz CT, Lansky AJ, Gerrits F, Kosinski AS, et al.Peripheral Artery Radiation Investigational Study (PARIS) Investigators. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. Journal of Vascular and Interventional Radiology 2001;12(8):915-21.
33. Pichler LJ, Hawliczek R, Somloi A, Mayrhofer R, Schmidt WF, Hruby W. Endovascular brachytherapy for the prevention of recurrence after PTA. Der Radiologe 1999;39(2):118-24.
34. Pokrajac B, Kirisits C, Schmid R, Schillinger M, Berger D, Peer K, et al.Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease. Cardiovascular Revascularization Medicine 2009;10(3):162-5.
35. Schopohl B, Leirmann D, Pohlit LJ, Heyd R, Strassmann G, Bauersachs R, et al.192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience. International Journal of Radiation Oncology, Biology, Physics 1996;36(4):835-40.
36. Minar E, Pokrajac B, Ahmadi R, Maca T, Seitz W, Stumpflen A, et al.Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology 1998;208(1):173-9.
37. Wolfram RM, Pokrajac B, Ahmadi R, Fellner C, Gyongyosi M, Haumer M, et al.Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. Radiology 2001;220(3):724-9.
38. Walichiewicz P, Piecuch J, Bialas B, Orkisz W, Fijalkowski M, Miszczyk L. Vascular brachytherapy after percutaneous transluminal angioplasty of superficial femoral arteries-Polish pilot group. Cardiovascular Radiation Medicine 2002;3(1):2-6.
39. Walichiewicz P, Piecuch J, Bialas B, Orkisz W, Fijalkowski M, Slosarek K, et al.Endovascular gamma irradiation of the iliac arteries: 1 year results from a clinical safety and feasibility study. Journal of Endovascular Therapy Jun 2003;10(3):573-6.
40. Werner M, Scheinert D, Henn M, Scheinert S, Bräunlich S, Bausback Y, et al.Endovascular brachytherapy using liquid Beta-emitting rhenium-188 for the treatment of long-segment femoropopliteal in-stent stenosis. Journal of Endovascular Therapy 2012;19(4):467-75.
41. Adar R, Critchfield GC, Eddy DM. A confidence profile analysis of the results of femoropopliteal percutaneous transluminal angioplasty in the treatment of lower extremity ischaemia. Journal of Vascular Surgery 1989;10(1):57-67.
42. Agency for Healthcare Research and Quality. Treatment strategies for patients with peripheral artery disease. Effective health care programme. Comparative effectiveness review number 118. http://www.effectivehealthcare.ahrq.gov/ehc/products/368/1517/peripheral-artery-disease-treatment-report-130525.pdf 2013.
43. Albiero R, Nishida T, Adamian M, Amato A, Vaghetti M, Corvaja N, et al.Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Circulation 2000;101(21):2454-7.
44. Bagga R, Kini A, Lee P, Agarwal A, Duffy M, Kim M, et al.Intracoronary brachytherapy for in-stent restenosis using long sources reduces restenosis. Journal of Invasive Cardiology 2005;17(6):302-6.
45. Bertrand OF, Mongrain R, Lehnert S, Bilodeau L, Tanguay JF, Laurier J, et al.Intravascular radiation therapy in atherosclerotic disease: promises and premises. European Heart Journal 1997;18(9):1385-95.
46. Bonvini R, Baumgartner I, Do DD, Alerci M, Segatto JM, Tutta P, et al.Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries. Journal of the American College of Cardiology 2003;41(3):409-12.
47. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Laboratory Investigation 1983;49(2):208-15.
48. Condado J, Gurdiel O, Espinoza R, Brito JG, Harrison ML, Joyner LR, et al.Percutaneous transluminal coronary angioplasty (PTCA) and intracoronary radiation therapy (ICRT): a possible new modality for the treatment of coronary restenosis: a preliminary report of the first 10 patients treated with intracoronary radiation therapy. Journal of the American College of Cardiology 1995;25(2s1):288A.
49. Condado JA, Waksman R, Gurdiel O, Espinosa R, Gonzalez J, Burger B, et al.Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997;96(3):727-32.
50. Condado JA, Waksman R, Calderas C, Saucedo J, Lansky A. Two-year follow-up after intracoronary gamma radiation therapy. Cardiovascular Radiation Medicine 1999;1(1):30-5.
51. Costa MA, Sabaté M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JM, et al.Late coronary occlusion after intracoronary brachytherapy. Circulation 1999;100(8):789-92.
52. Davies MG, Anaya-Ayala JE. Endovascular techniques in limb salvage: cutting, cryo, brachy, and drug-eluting balloons. Methodist Debakey Cardiovascular Journal 2013;9(2):69-72.
53. Dewhurst G, Wood DA, Walker F, Lampe FC, Jeffreys M, Cooper M, et al.A population survey of cardiovascular disease in elderly people: design, methods and prevalence results. Age and Ageing 1991;20(5):353-60.
54. Diehm N, Silvestro A, Do DD, Greiner R, Triller J, Mahler F, et al.Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time. Journal of Endovascular Therapy 2005;12(6):723-30.
55. Dilley RJ, McGeachie JK, Prendergast FJ. A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia. Archives of Surgery 1988;123(6):691-6.
56. Dormandy JA, Murray GD. The fate of the claudicant--a prospective study of 1969 claudicants. European Journal of Vascular Surgery 1991;5(2):131-3.
57. Eising EG, Wieneke H. Is there a relation between 'candy wrapper, ' prevention of (for instance) coronary artery disease, and therapy of postdiscectomy syndrome by irradiation?. Cardiovascular Radiation Medicine 2001;2(2):104-6.
58. Feres F, Muñoz JS, Abizaid A, Albertal M, Mintz GS, Staico R, et al.Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis. American Journal of Cardiology 2005;96(12):1656-62.
59. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral vascular disease in the general population. International Journal of Epidemiology 1991;20(2):384-92.
60. Fowkes FG, Gillespie IN. Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: 10.1002/14651858.CD000017]
61. Gorenoi V, Dintsios CM, Schönermark MP, Hagen A. Intravascular brachytherapy for peripheral arterial occlusive disease: systematic review of medical efficacy and health economic modelling [Intravaskuläre Brachytherapie bei peripherer arterieller Verschlusskrankheit: Systematische Übersicht zur medizinischen Wirksamkeit und gesundheitsökonomische Modellierung]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2009;103(6):331-40.
62. Hagenaars T, Apo IF, Van Sambeek MR, Coen VL, Van Tongeren RB, Gescher FM, et al.Gamma radiation induces positive vascular remodeling after balloon angioplasty: a prospective, randomized intravascular ultrasound scan study. Journal of Vascular Surgery 2002;36(2):318-24.
63. Hall E. Radiobiology for the radiologists. 4th Edition. Philadelphia: JB Lippincott Company, 1994.
64. Hanefeld C, Amirie S, Borchardt D, Grewe P, Müller KM, Kissler M, et al.Dosimetric measurements in isolated human coronary arteries: comparison of commercially available iridium(192) with strontium/yttrium(90) emitters. Circulation 2002;105(21):2493-6.
65. Hehrlein C, Stintz M, Kinscherf R, Schlösser K, Huttel E, Friedrich L, et al.Pure beta-particle-emitting stents inhibit neointima formation in rabbits. Circulation 1996;93(4):641-5.
66. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic reviews of Interventions Version 5.1.0 [updated March 2011]. Wiley-Blackwell, 2011.
67. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al.ACC/AHA Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)-summary of recommendations. Circulation 2006;113(11):e463-654.
68. Hofmann WJ, Kopp M, Kofler B, Ugurluoglu A, Kogelnik D, Magometschnigg H. Preliminary observations on the need for control angiography after peripheral endovascular brachytherapy using a centering balloon. Journal of Endovascular Therapy 2002;9(2):241-5.
69. King SB 3rd, Williams DO, Chougule P, Klein JL, Waksman R, Hilstead R, et al.Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998;97(20):2025-30.
70. Kudo T, Chandra FA, Ahn SS. Long-term outcomes and predictors of iliac angioplasty with selective stenting. Journal of Vascular Surgery 2005;42(3):466-75.
71. Kudo T, Chandra FA, Kwun WH, Haas BT, Ahn SS. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. Journal of Vascular Surgery 2006;44(2):304-13.
72. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, et al.Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. New England Journal of Medicine 2001;344(4):250-6.
73. Leu AJ, Schneidner E, Canova CR, Hoffman U. Long-term results after recanalisation of chronic iliac artery occlusions by combined catheter therapy without stent placement. European Journal of Vascular and Endovascular Surgery 1999;18(6):499-505.
74. Leville CD, Kashyap VS, Clair DG, Bena JF, Lyden SP, Greenberg RK, et al.Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. Journal of Vascular Surgery 2006;43(1):32-9.
75. London NJ, Varty K, Sayers RD, Thompson MM, Bell PR, Bolia A. Percutaneous transluminal angioplasty for lower-limb critical ischaemia. British Journal of Surgery 1995;82(9):1232-5.
76. Long AL, Page PE, Raynaud AC, Beyssen BM, Fiessinger JN, Ducimetiere P, et al.Percutaneous iliac artery stent: angiographic long-term follow-up. Radiology 1991;180(3):771-8.
77. Mannava K, Money SR. Current management of peripheral arterial occlusive disease: a review of pharmacologic agents and other interventions. American Journal of Cardiovascular Drugs 2007;7(1):59-66.
78. Martin EC, Katzen BT, Benenati JF, Diethrich EB, Dorros G, Graor RA, et al.Multicenter trial of the wall stent in the iliac and femoral arteries. Journal of Vascular and Interventional Radiology 1995;6(6):843-9.
79. Minar E. Resuscitation of endovascular brachytherapy owing to improved logistics. Journal of Endovascular Therapy 2012;19(4):476-9.
80. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, et al.Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94(1):35-43.
81. Mintz GS, Weissman NJ, Teirstein PS, Ellis SG, Waksman R, Russo RJ, et al.Effect of intracoronary gamma-radiation therapy on in-stent restenosis: An intravascular ultrasound analysis from the gamma-1 study. Circulation 2000;102(24):2915-8.
82. Mitchell D, O'Callaghan AP, Boyle EM, Kavanagh EG, Walsh SR. Endovascular brachytherapy and restenosis following lower limb angioplasty: Systematic review and meta-analysis of randomized clinical trials. International Journal of Surgery 2012;10(3):124-8.
83. Murphy KD, Encarnacion CE, Le VA, Palmaz JC. Iliac artery stent placement with the Palmaz stent: follow-up study. Journal of Vascular and Interventional Radiology 1995;6(3):321-9.
84. Nath R, Amols H, Coffey C, Duggan D, Jani S, Li Z, et al.Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no.60. American Association of Physicists in Medicine. Medical Physics 1999;26(2):119-52.
85. Park KB, Do YS, Kim JH, Han YH, Kim DI, Kim DK, et al.Stent placement for chronic iliac arterial occlusive disease:the results of 10 years experience in a single institution. Korean Journal of Radiology 2005;6(4):256-66.
86. Park KB, Do YS, Kim DI, Kim DK, Kim YW, Shin SW, et al.The TransAtlantic InterSociety Consensus (TASC) classification system in iliac arterial stent placement: long-term patency and clinical limitations. Journal of Vascular and Interventional Radiology 2007;18(2):193-201.
87. Pokrajac B, Schmid R, Kirisits C, Mock U, Fellner C, Wambersie A, et al.Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. Radiotherapy and Oncology 2002;63(1):97-102.
88. Pokrajac B, Minar E, Kirisits C, Potter R. Present status of endovascular brachytherapy in peripheral arteries. Herz 2002;27(1):56-61.
89. Pokrajac B, Kirisits C, Schmid R, Schillinger M, Berger D, Peer K, et al.Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease. Cardiovascular Revascularization Medicine 2009;10(3):162-5.
90. Rorat E, Petelenz B, Marczewska B, Ochab E. Thermoluminescence dosimetry of model line sources containing vanadium-48. Radiation Measurements 2005;39(5):495-501.
91. Rutherford RB, Durham JD. Percutaneous balloon angioplasty for arteriosclerosis obliterans: long-term results. In: Yoa JST, Pearce W editor(s). Technologies in vascular surgery. Philadelphia: WB Saunders, 1991:329-45.
92. Rutherford RB, Durham JD, Kumpe DA. Endovascular intervention for lower extremity ischemia. In: Rutherford RB editor(s). Vascular Surgery - IV edition. Orlando: WB Saunders, 1995:858-74.
93. Sabate M, Serruys PW, van der Giessen WJ, Ligthart JM, Coen VL, Kay IP, et al.Geometric vascular remodeling after balloon angioplasty and beta-radiation therapy: A three-dimensional intravascular ultrasound study. Circulation 1999;100(11):1182-8.
94. Salame M, Lampkin J, Mulkey SP, Cui J, Verheye S, Hillstead RA, et al.Effects of endovascular irradiation on platelet recruitment at sites of balloon angioplasty in pig coronary arteries. Journal of the American College of Cardiology 1999;33:44A Abstract No. 1070-60.
95. Sapirstein W, Zuckerman B, Dillard J. FDA approval of coronary-artery brachytherapy. New England Journal of Medicine 2001;344(4):297-9.
96. Schillinger M, Mlekusch W, Wolfram RM, Budinsky AC, Exner M, Rumpold H, et al.Endovascular brachytherapy: effect on acute inflammatory response after percutaneous femoropopliteal arterial interventions. Radiology 2004;230(2):556-60.
97. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, et al.Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996;93(12):2178-87.
98. Scott NA, Wilcox JN. The role of adventitial vasculature in restenosis: a new view of an old problem. Journal of the American College of Cardiology 1998;32(7):2080.
99. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999 - 2000. Circulation 2004;110(6):738-43.
100. Simpson EL, Michaels JA, Thomas SM, Cantrell AJ. Systematic review and meta-analysis of additional technologies to enhance angioplasty for infrainguinal peripheral arterial occlusive disease. British Journal of Surgery 2013;100(9):1128-37.
101. Sottiurai VS, Yao JS, Flinn WR, Batson RC. Intimal hyperplasia and neointima: An ultrastructural analysis of thrombosed grafts in humans. Surgery 1983;93(6):809-17.
102. Stansby G, Mister R, Fowkes G, Roughton M, Nugara F, Brittenden J, et al.High risk of peripheral arterial disease in the United Kingdom: 2-year results of a prospective registry. Angiology 2011;62(2):111-8.
103. Technology Evaluation Center. Brachytherapy for the prevention of restenosis in peripheral arteries following PTA of the femoropopliteal system. Technology evaluation center assessment program 2003;17(22):1-17.
104. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, et al.Catheter-based radiotherapy to inhibit restenosis after coronary stenting. New England Journal of Medicine 1997;336(24):1697-703.
105. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, et al.Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000;101(4):360-5.
106. Verin V, Popowski Y, Urban P, Belenger J, Redard M, Costa M, et al.Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation 1995;92(8):2284-90.
107. Verin V, Popowski Y, de Bruyne B, Baumgart D, Sauerwein W, Lins M, et al.for the Dose-Finding Study Group. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. New England Journal of Medicine 2001;344(4):243-9.
108. Virmani R, Farb A. Assessing the advantages and disadvantages of novel radiation therapy for vascular restenosis: injury score, artery size, and short lengths. Cardiovascular Radiation Medicine 1999;1(3):308-10.
109. Vodovotz Y, Waksman R, Kim WH, Bhargava B, Chan RC, Leon M. Effects of intracoronary radiation on thrombosis following balloon overstretch injury in the porcine model. Circulation 1999;100(25):2527-33.
110. Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB 3rd. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention. Circulation 1995;91(5):1533-9.
111. Waksman R, Robinson KA, Crocker IR, Wang C, Gravanis MB, Cipolla GD, et al.Intracoronary low-dose beta-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model. Circulation 1995;92(10):3025-31.
112. Waksman R, Rodriguez JC, Robinson KA, Cipolla GD, Crocker IR, Scott NA, et al.Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1997;96(6):1944-52.
113. Waksman R. Intracoronary radiation therapy for restenosis prevention: status of the clinical trials. Cardiovascular Radiation Medicine 1999;1(1):20-9.
114. Waksman R. Late thrombosis after radiation. Sitting on a time bomb. Circulation 1999;100(8):780-2.
115. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, et al.Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101(18):2165-71.
116. Waksman R, Bhargava B, Leon MB. Late thrombosis following intracoronary brachytherapy. Catheterization and Cardiovascular Interventions 2000;49(3):344-7.
117. Weinberger J, Amols H, Ennis RD, Schwartz A, Wiedermann JG, Marboe C. Intracoronary irradiation: dose response for the prevention of restenosis in swine. International Journal of Radiation Oncology, Biology, Physics 1996;36(4):767-75.
118. Wiedermann JG, Marboe C, Amols H, Schwartz A, Weinberger J. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. Journal of the American College of Cardiology 1994;23(6):1491-8.
119. Wilcox JN, Waksman R, King SB, Scott NA. The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. International Journal of Radiation Oncology, Biology, Physics 1996;36(4):789-96.
120. Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E. Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery--the Vienna experience. Radiology 2005;236(1):338-42.
121. Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up--prospective randomized study. Radiology 2006;240(3):878-84.
122. Wu YP, Stella PR, Chen SF, Wang YT, Wang JY, Moerland MA, et al.β-radiation reduces the reactivity of extracellular matrix proteins in intravascular brachytherapy (IVBT), resulting in decreased platelet adhesion. International Journal of Cardiology 2012;156(3):283-8.
123. Wyttenbach R, Gallino A, Alerci M, Mahler F, Cozzi L, Di Valentino M, et al.Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 2004;110(9):1156-61.
124. Wyttenbach R, Corti R, Alerci M, Cozzi L, Di Valentino M, Segatto JM, et al.Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery: 2 years follow-up by noninvasive magnetic resonance imaging. European Journal of Vascular and Endovascular Surgery 2007;34:416-23.
125. Hansrani M, Overbeck K, Smout JJ, Stansby GP. Intravascular brachytherapy for peripheral vascular disease. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD003504]